RULEMAKING: Public Health - Final Rule

Consumable Hemp Products Final Rule in accordance with Act 336 of the 2021 Regular Legislature.

This Rule adds Spinal Muscular Atrophy (SMA), Mucopolysaccharidosis (MPS I), and Glycogen Storage Diseases Type II (Pompe Disease) to the Louisiana Newborn Screening Panel.

This rule amends §701 of Chapter 7 of Title 51—Public Health Immunization Requirements. The amendments add vaccines for SARS-CoV-2 to the list of required vaccinations for school entry to the extent that such vaccines are approved by the Food and Drug Administration for the individual’s age, and also require such vaccines, and all potential boosters, on the same basis for school attendance.

Under the authority of R.S. 36:254(B)(7) and in accordance with R.S. 49:950 et seq., the Administrative Procedure Act, the Department of Health, Office of Public Health (LDH-OPH), has amended Chapter 80 (Accreditation of Laboratories Performing Drinking Water Analyses) of Subpart 28 (Drinking Water Laboratories) of Part V (Preventive Health Services) of Title 48 (Public Health?General) of the Louisiana Administrative Code (LAC). The amendments are necessary to withdraw the LDH-OPH Laboratory Certification Program from The NELAC Institute (TNI), the National Environmental Laboratory Accreditation Program (NELAP).